A 24-week, Double-blind, Randomized, Placebo-controlled, Multicenter Study, to Evaluate the Effectiveness of Cyclosporine 2,5 mg/kg/Day Bid Twice a Week on Reducing Relapse Rate, in Maintenance Patients With Chronic Plaque Psoriasis
Phase of Trial: Phase III
Latest Information Update: 02 May 2016
At a glance
- Drugs Ciclosporin (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Novartis
- 13 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2009 New trial record.